Sign in

CIK 0000025743

  • Non-accelerated filer
  • Smaller reporting company

TherapeuticsMD, Inc.

Sign in to watch
Ticker
TXMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
870233535
Phone
+1 561-961-1900
Business address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
Former names
AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Director acquired 312,525 shares (grant or award)
  3. 4/A Open-market sale Chief Executive Officer sold 692 shares at $3.64 ($2,518)
  4. 4 Open-market sale Chief Executive Officer sold 1,170 shares at $3.65 ($4,276)
  5. 4 Exercise or conversion Prin. Fin. and Acctg. Officer acquired 50,000 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4/A Returned to the company Director returned 29,000 shares (to the company)
  9. 5 Insider Annual Insider Trading Report
  10. 4 Open-market sale Prin. Fin. and Acctg. Officer sold 1,697 shares at an average $5.08 ($8,621)
  11. 4 Open-market sale Prin. Fin. and Acctg. Officer sold 1,309 shares at an average $5.34 ($6,988)
  12. 4 Open-market sale 10% owner sold 29,000 shares at $1,333.00 ($38,657,000)
  13. 4 Open-market buy 10% owner bought 14,825 shares at $6.09 ($90,284)
  14. 4 Open-market sale Co-Chief Executive Officer sold 1,255 shares at an average $5.28 ($6,621)
  15. 4 Open-market sale General Counsel sold 1,048 shares at $4.95 ($5,185)
  16. 4 Open-market sale Co-Chief Executive Officer sold 440 shares at $4.92 ($2,165)
  17. 4 Open-market sale Interim CFO/CAO/VP of Finance sold 910 shares at $4.78 ($4,345)
  18. 4 Open-market buy 10% owner bought 20,413 shares at an average $5.66 ($115,639)
  19. 4 Open-market sale Director sold 3,922 shares at $5.26 ($20,635)
  20. 4 Open-market buy 10% owner bought 7,000 shares at $1,000.00 ($7,000,000)

Page 2 of 22 · 428 filings